Retrieved from MedlinePlus-a
1 To further understand what factors might influence whether patients were likely to maintain, regain, or lose more weight, we studied 25,552 patients prescribed semaglutide and 33,456 patients prescribed liraglutide for at least 90 days continuously between January 1, 2017, and February 1, 2023
Ozempic is also approved to help: reduce your risk of certain heart conditions if you have known heart disease and type 2 diabetes prevent the progression of kidney disease and fatal heart problems if you have chronic kidney disease and type 2 diabetes Ozempic contains the active ingredient semaglutide, a glucagon-like peptide-1 receptor (GLP-1) agonist (also called GLP-1 agonists)
[DOI] [PubMed] [Google Scholar] 64.Siddeeque N., Hussein M.H., Abdelmaksoud A., Bishop J., Attia A.S., Elshazli R.M., Fawzy M.S., Toraih E.A
La edad promedio en el inicio del estudio fue de 66 aos y el 68% de los pacientes eran hombres